LLY

1,050.93

+2.96%↑

JNJ

248.43

+2.06%↑

ABBV

231.99

+3.33%↑

NVS

168.32

+1.89%↑

MRK

123.72

+3.77%↑

LLY

1,050.93

+2.96%↑

JNJ

248.43

+2.06%↑

ABBV

231.99

+3.33%↑

NVS

168.32

+1.89%↑

MRK

123.72

+3.77%↑

LLY

1,050.93

+2.96%↑

JNJ

248.43

+2.06%↑

ABBV

231.99

+3.33%↑

NVS

168.32

+1.89%↑

MRK

123.72

+3.77%↑

LLY

1,050.93

+2.96%↑

JNJ

248.43

+2.06%↑

ABBV

231.99

+3.33%↑

NVS

168.32

+1.89%↑

MRK

123.72

+3.77%↑

LLY

1,050.93

+2.96%↑

JNJ

248.43

+2.06%↑

ABBV

231.99

+3.33%↑

NVS

168.32

+1.89%↑

MRK

123.72

+3.77%↑

Search

ResMed Inc

Fechado

SetorSaúde

255.35 -0.39

Visão Geral

Variação de preço das ações

24h

Atual

Mín

254.04

Máximo

256.35

Indicadores-chave

By Trading Economics

Rendimento

44M

393M

Vendas

87M

1.4B

P/E

Médio do Setor

25.77

108.767

Rendimento de Dividendos

0.87

Margem de lucro

27.593

Funcionários

10,600

EBITDA

63M

566M

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+17.32% upside

Dividendos

By Dow Jones

Rendimento de Dividendos

Médio do Setor

0.87%

2.21%

Próximos Ganhos

22 de abr. de 2026

Próxima data de dividendos

19 de mar. de 2026

Próxima data de ex-dividendo

7 de mai. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

777M

38B

Abertura anterior

255.74

Fecho anterior

255.35

Sentimento de Notícias

By Acuity

19%

81%

23 / 352 Ranking em Healthcare

ResMed Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

27 de fev. de 2026, 23:53 UTC

Ações em Alta

Stocks to Watch: Aardvark Therapeutics, Blue Moon Metals

27 de fev. de 2026, 22:23 UTC

Aquisições, Fusões, Aquisições de Empresas

Blue Moon Metals To Acquire Apex Germanium Mine From Teck Subsidiary

1 de mar. de 2026, 00:00 UTC

Notícias Principais

Trump's War on Iran Threatens to Drive Up Oil Prices and Inflation -- WSJ

28 de fev. de 2026, 21:36 UTC

Ganhos

Berkshire Hathaway Operating Earnings Fell 30% in Fourth Quarter. There Were No Stock Buybacks. -- Barrons.com

28 de fev. de 2026, 15:20 UTC

Ganhos

Berkshire's Abel Pledges to Follow Buffett's 'Framework' in First Shareholder Letter -- 2nd Update

28 de fev. de 2026, 14:43 UTC

Ganhos

Berkshire Hathaway Operating Earnings Fell 30% in Fourth Quarter. There Were No Stock Buybacks. -- Barrons.com

28 de fev. de 2026, 14:40 UTC

Notícias Principais

What Defense Stocks Stand to Gain -- and Lose -- From the U.S. Attacks on Iran -- Barrons.com

28 de fev. de 2026, 14:38 UTC

Ganhos

Berkshire's Abel Pledges to Follow Buffett's 'Framework' in First Shareholder Letter -- Update

28 de fev. de 2026, 13:51 UTC

Notícias Principais

What Defense Stocks Stand to Gain--and Lose--From the US Attacks on Iran -- Barrons.com

28 de fev. de 2026, 13:47 UTC

Ganhos

Berkshire Hathaway Operating Earnings Fell 30% in Fourth Quarter. There Were No Stock Buybacks. -- Barrons.com

28 de fev. de 2026, 13:44 UTC

Ganhos

Berkshire Hathaway Earnings Slip on Decline in Insurance Results -- WSJ

28 de fev. de 2026, 13:14 UTC

Ganhos

Berkshire Hathaway Operating Earnings Fell 30% in Fourth Quarter. There Were No Stock Buybacks. -- Barrons.com

28 de fev. de 2026, 12:41 UTC

Notícias Principais

Iran's Rulers Face an All-Out Battle for Survival -- Barrons.com

28 de fev. de 2026, 10:30 UTC

Aquisições, Fusões, Aquisições de Empresas

All The Ways Netflix Actually Won Even Though It Lost Warner -- Heard on the Street -- WSJ

28 de fev. de 2026, 02:32 UTC

Ganhos
Aquisições, Fusões, Aquisições de Empresas

Calpers Buys Into Hot Chip And Quantum Stocks -- Barrons.com

28 de fev. de 2026, 02:00 UTC

Aquisições, Fusões, Aquisições de Empresas

Six Months, 9 Offers and $81 Billion. How Hollywood's Nasty Takeover Was Won. -- WSJ

28 de fev. de 2026, 02:00 UTC

Aquisições, Fusões, Aquisições de Empresas

Six Months, 9 Offers and $81 Billion. How -2-

28 de fev. de 2026, 00:01 UTC

Aquisições, Fusões, Aquisições de Empresas

Paramount Issuing $47 Billion of Equity at Big Premium to Stock Price for Warner Bros. Deal -- Barrons.com

27 de fev. de 2026, 23:46 UTC

Aquisições, Fusões, Aquisições de Empresas

Netflix Walks Away a Winner After Losing Warner Bros. to Paramount -- Barrons.com

27 de fev. de 2026, 23:33 UTC

Aquisições, Fusões, Aquisições de Empresas

Paramount Issuing $47 Billion of Equity at Nearly 20% Premium to Current Stock Price -- Barrons.com

27 de fev. de 2026, 21:50 UTC

Conversa de Mercado
Aquisições, Fusões, Aquisições de Empresas

Tech, Media & Telecom Roundup: Market Talk

27 de fev. de 2026, 21:50 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

27 de fev. de 2026, 21:30 UTC

Ganhos

Solventum Beat Wall Street Earnings Estimates. The Stock Falls. -- Barrons.com

27 de fev. de 2026, 21:30 UTC

Conversa de Mercado
Aquisições, Fusões, Aquisições de Empresas

Warner Terminates Netflix Deal, Ending Monthslong Saga -- Market Talk

27 de fev. de 2026, 21:20 UTC

Aquisições, Fusões, Aquisições de Empresas

Blue Moon Metals to Buy Apex Germanium and Gallium Mine From Teck >BMM

27 de fev. de 2026, 21:17 UTC

Ganhos

These Stocks Are Today's Movers: Netflix, Paramount, Block, Sunrun, Dell, Rocket Lab, Nvidia, CoreWeave, and More -- Barrons.com

27 de fev. de 2026, 21:10 UTC

Aquisições, Fusões, Aquisições de Empresas

Blue Moon Metals Evaluating Options for a New Processing Line at Springer Complex to Process the Apex Material

27 de fev. de 2026, 21:09 UTC

Aquisições, Fusões, Aquisições de Empresas

Blue Moon Metals to Acquire the Apex Germanium and Gallium Mine From Teck

27 de fev. de 2026, 21:00 UTC

Ganhos

Nike: 3Q Results to Be Released March 31 to Accommodate for Several Holidays >NKE

27 de fev. de 2026, 20:31 UTC

Aquisições, Fusões, Aquisições de Empresas

Netflix Receives $2.8B Termination Fee Under Terminated Warner Bros. Discovery Deal

Comparação entre Pares

Variação de preço

ResMed Inc Previsão

Preço-alvo

By TipRanks

17.32% parte superior

Previsão para 12 meses

Média 300.64 USD  17.32%

Máximo 345 USD

Mínimo 265 USD

Com base em 13 analistas de Wall Street que oferecem metas de preço de 12 meses para ResMed Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

13 ratings

8

Comprar

5

Manter

0

Vender

Sentimento

By Acuity

23 / 352 Ranking em Saúde

Sentimento de Notícias

Evidência Muito Forte de Tendência de Alta

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Abaixo da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre ResMed Inc

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
help-icon Live chat